Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
December 2, 2021

Coronavirus company news summary – Vitiprints to supply 60 million Viracide Masks to South Africa – study finds that blood test can help predict Covid-19 severity

By Kezia Parkins

Vitiprints has secured a contract from Uvukile Medical and Surgical Supplies to deliver 60 million Viracide Masks to South Africa. These South African Health Products Regulatory Authority (SAHPRA)-approved masks have an antiviral and antibacterial coating designed to deactivate Covid-19 upon contact. According to the company, the coating is capable of deactivating 99.97% of SARS-CoV-2 and 99% of Human Coronavirus (229E) in under one minute of contact thereby reducing transmission of the disease.

US-based molecular diagnostics company Cepheid has said that its PCRplus-based Xpert coronavirus tests are expected to detect the new Covid-19 variant Omicron. An in-silico (computer-based) analysis found that the company’s Xpert Xpress SARS-CoV-2, Xpert Xpress SARS-CoV-2/Flu/RSV, and Xpert Xpress CoV-2/Flu/RSV plus tests are apparently unaffected by the Omicron variant. The tests are designed to target multiple genes to ensure accurate virus detection.

A team of researchers at Nagourney Cancer Institute in the US and Metabolomycs, INC have announced that a metabolism-based blood test at the time of diagnosis can help in predicting Covid-19 related illness severity and fatality risks. The findings are based on a study that included 82 patients with RT-PCR confirmed Covid-19. The blood samples obtained from these patients were assessed for biochemical composition using quantitative mass spectrometry to quantify metabolites. According to the investigators, these metabolic signatures can help in determining the severity of Covid-19 infection.

Related Companies

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU